The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus
- PMID: 12136916
The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus
Abstract
Objective: To determine the incidence and prevalence of neuropsychiatric systemic lupus erythematosus (NPSLE) and glomerulonephritis in ethnically diverse pediatric onset SLE inpatient and outpatient populations.
Methods: Seventy-five pediatric onset patients with SLE including Native American, Asian, Black, Spanish-American, and Caucasian subjects were evaluated prospectively and cross sectionally. During the 6 year study, 55 patients became inpatients. Subjects underwent medical interview, physical examination, laboratory review, neuropsychiatric inventory, and chart review. Classification of NPSLE was accomplished with the 1999 ACR NPSLE case definitions.
Results: Prospectively, NPSLE occurred in 95% of pediatric SLE patients and was more common than glomerulonephritis (55%; p < or = 0.0001). NPSLE prevalence (%) and incidence (event/person/yr) were as follows: headache 72%, 95; mood disorder 57%, 0.41; cognitive disorder 55%, 0.49; seizure disorder 51%, 0.94; acute confusional state 35%, 0.6; anxiety disorder 21%, 0.28; peripheral nervous system disorder 15%, 0.16; cerebrovascular disease 12%, 0.32; psychosis 12%, 0.16; chorea 7%, 0.01; demyelinating syndrome 4%, 0.01; and myelopathy 1%, 0.001. Cross sectionally, active NPSLE was present in 93% of inpatients and 69% of outpatients. When only serious forms of NPSLE were considered (stroke, seizures, major cognitive disorder, chorea, psychosis, major depression, acute confusional state), serious or life-threatening NPSLE occurred in 76% of all SLE subjects prospectively, and in 85% and 40% of inpatients and outpatients cross sectionally, which in each instance was more common than glomerulonephritis (p < or = 0.001).
Conclusion: NPSLE is one of the most common serious complications of pediatric SLE, and is particularly increased in pediatric inpatients.
Similar articles
-
Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.J Rheumatol. 2001 Apr;28(4):766-71. J Rheumatol. 2001. PMID: 11327248
-
Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.J Rheumatol. 2003 May;30(5):985-92. J Rheumatol. 2003. PMID: 12734893
-
Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus.J Clin Rheumatol. 2006 Feb;12(1):3-10. doi: 10.1097/01.rhu.0000200378.42836.7f. J Clin Rheumatol. 2006. PMID: 16484873
-
Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.Lupus. 2006;15(10):651-7. doi: 10.1177/0961203306070990. Lupus. 2006. PMID: 17120591 Review.
-
Psychiatric manifestations in systemic lupus erythematosus.Autoimmun Rev. 2007 Jun;6(6):421-6. doi: 10.1016/j.autrev.2007.02.007. Epub 2007 Mar 12. Autoimmun Rev. 2007. PMID: 17537389 Review.
Cited by
-
Diagnosis and management of neuropsychiatric SLE.Nat Rev Rheumatol. 2014 Jun;10(6):338-47. doi: 10.1038/nrrheum.2014.15. Epub 2014 Feb 11. Nat Rev Rheumatol. 2014. PMID: 24514913 Review.
-
Elevated serum neurofilament light chain levels in patients with neuropsychiatric systemic lupus erythematosus: a cross-sectional study.Lupus Sci Med. 2025 Jan 19;12(1):e001309. doi: 10.1136/lupus-2024-001309. Lupus Sci Med. 2025. PMID: 39832906 Free PMC article.
-
A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus.Arthritis Care Res (Hoboken). 2010 Jul;62(7):1029-33. doi: 10.1002/acr.20152. Arthritis Care Res (Hoboken). 2010. PMID: 20589693 Free PMC article.
-
Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.Arthritis Rheumatol. 2019 Feb;71(2):281-289. doi: 10.1002/art.40764. Epub 2019 Jan 18. Arthritis Rheumatol. 2019. PMID: 30375754 Free PMC article.
-
Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers.J Clin Immunol. 2023 Apr;43(3):615-624. doi: 10.1007/s10875-022-01407-1. Epub 2022 Dec 5. J Clin Immunol. 2023. PMID: 36469191 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical